Defibrillator News and Research RSS Feed - Defibrillator News and Research

An implantable cardioverter defibrillator (ICD) is a small device that's placed in your chest or abdomen. This device uses electrical pulses or shocks to help control life-threatening, irregular heartbeats, especially those that could lead the heart to suddenly stop beating (sudden cardiac arrest). If the heart stops beating, blood stops flowing to the brain and other vital organs. This usually causes death if it's not treated in minutes.
Study: Around 6% survive cardiac arrest outside of hospital setting

Study: Around 6% survive cardiac arrest outside of hospital setting

Cardiac arrest strikes almost 600,000 people each year, killing the vast majority of those individuals, says a new report from the Institute of Medicine. Every year in the U.S., approximately 395,000 cases of cardiac arrest occur outside of a hospital setting, in which less than 6 percent survive. Approximately 200,000 cardiac arrests occur each year in hospitals, and 24 percent of those patients survive. Estimates suggest that cardiac arrest is the third leading cause of death in the U.S. behind cancer and heart disease. [More]
Life-saving defibrillators are grossly underutilized, shows study

Life-saving defibrillators are grossly underutilized, shows study

Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the American Medical Association. [More]
UCSF researchers propose systematic methods to determine causes of death in patients with CIEDs

UCSF researchers propose systematic methods to determine causes of death in patients with CIEDs

The current monitoring of patients with cardiac implantable electronic devices (CIEDs) such as pacemakers and defibrillators may be underestimating device problems, according to UC San Francisco researchers who propose systematic methods to determine accurate causes of sudden death in those with CIEDs as well as improved monitoring for device concerns. [More]
Cardiac device wearers ought to keep safe distance from smartphones to prevent unwanted painful shocks

Cardiac device wearers ought to keep safe distance from smartphones to prevent unwanted painful shocks

Cardiac device wearers should keep a safe distance from smartphones to avoid unwanted painful shocks or pauses in function, reveals research presented today at EHRA EUROPACE -- CARDIOSTIM 2015 by Dr. Carsten Lennerz, first author and cardiology resident in the Clinic for Heart and Circulatory Diseases, German Heart Centre, Munich, Germany. [More]
Research reveals how a faulty gene can cause fatal abnormal heart rhythms during exercise

Research reveals how a faulty gene can cause fatal abnormal heart rhythms during exercise

University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise. [More]
CVRx announces presentation of positive data from Barostim Therapy for Heart Failure clinical trial at HRS 2015

CVRx announces presentation of positive data from Barostim Therapy for Heart Failure clinical trial at HRS 2015

CVRx, Inc., a private medical device company, announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled clinical trial were presented at the 2015 annual Scientific Sessions of the Heart Rhythm Society (HRS) in a Late-Breaking Clinical Trial Session. Results were presented by Dr. Michael Zile from the Medical University of South Carolina. [More]
Recent CE Mark approvals expand St. Jude Medical’s MRI-compatible device portfolio in Europe

Recent CE Mark approvals expand St. Jude Medical’s MRI-compatible device portfolio in Europe

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse implantable cardioverter defibrillator (ICD), in addition to its Durata and Optisure defibrillation leads, allowing existing or future patients with these technologies to undergo magnetic resonance imaging (MRI) scans without compromising device performance. [More]
Study sheds light on the physical causes of sudden death

Study sheds light on the physical causes of sudden death

Sudden cardiac death accounts for approximately 10% of natural deaths, most of which are due to ventricular fibrillation. Each year it causes 300,000 deaths in the United States and 20,000 in Spain. [More]
Catheter ablation more beneficial to heart failure patients than Amiodarone treatment

Catheter ablation more beneficial to heart failure patients than Amiodarone treatment

Among patients with heart failure and atrial fibrillation, those who underwent catheter ablation were less likely to die, be hospitalized or have recurrent atrial fibrillation than patients taking a heart rhythm regulating drug, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session. [More]
Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

Sudden cardiac arrest is a possible cause of death in patients with non-ischaemic cardiac muscle weakness, i.e. a type of heart failure caused by genetics or for which no cause is known. Now, researchers at the University Department of Internal Medicine II at the MedUni Vienna (Clinical Department of Cardiology), as part of an international cooperation, have successfully demonstrated the advantages of an implanted defibrillator (ICD) as a means of prevention in patients with moderately restricted cardiac function, and that patients with the condition must be treated as carefully as patients with ischaemic heart failure which has developed following a heart attack, for example. [More]
Boston Scientific announces launch of EL implantable cardioverter defibrillators

Boston Scientific announces launch of EL implantable cardioverter defibrillators

Boston Scientific Corporation announces the launch and first U.S. implant of its line of Extended Longevity (EL) implantable cardioverter defibrillators (ICD), including DYNAGEN EL and INOGEN EL device models. [More]

Reducing the risk of sudden cardiac arrest during sports

Time and again, the topic of sudden cardiac death grabs the public's attention when football stars or other top athletes collapse from cardiac arrest in front of the live cameras. This important issue has long been a concern of heart specialists, for cardiac arrest often hits young, apparently healthy and athletic people out of the blue. [More]
Advances in fight against TB, sudden cardiac death

Advances in fight against TB, sudden cardiac death

Research projects into two of the biggest killers in worldwide health, tuberculosis and sudden cardiac death, will be the subjects of the University of Leicester Graduate School Doctoral Inaugural Lectures, delivered by two of the winners of this year's PhD prizes in the College of Medicine, Biological Sciences and Engineering. [More]
Implementing risk management practices necessary in health and fitness centers

Implementing risk management practices necessary in health and fitness centers

Health is high on the agenda in many countries with efforts to get more people exercising in order to reduce the problems associated with obesity, such as diabetes, cardiovascular disease and cancer. [More]
St. Jude Medical gets CE Mark approval for updated labeling of Tendril STS, IsoFlex Optim pacing leads

St. Jude Medical gets CE Mark approval for updated labeling of Tendril STS, IsoFlex Optim pacing leads

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of updated labeling for its Tendril STS and IsoFlex Optim pacing leads, allowing existing and future patients with the devices access to magnetic resonance imaging (MRI) scans. [More]
3D-printed heart model created by Materialise

3D-printed heart model created by Materialise

Materialise (Nasdaq:MTLS), a pioneer in 3D Printing for medical applications, recently created a 3D-printed heart model for doctors at Cincinnati Children’s Hospital to support Bradley White’s case, a 16-year-old boy who was born with a tumor. With the aid of Materialise’s HeartPrint® 3D-printed model, his doctors were able to determine the best treatment for Bradley’s erratic heartbeat. [More]
Measuring levels of sex hormones in patients' blood may identify risk of sudden cardiac arrest

Measuring levels of sex hormones in patients' blood may identify risk of sudden cardiac arrest

Measuring the levels of sex hormones in patients' blood may identify patients likely to suffer a sudden cardiac arrest, a heart rhythm disorder that is fatal in 95 percent of patients. [More]
BIOTRONIK Home Monitoring reduces mortality in heart failure patients, saves costs

BIOTRONIK Home Monitoring reduces mortality in heart failure patients, saves costs

Experts discussed the benefits of Home Monitoring technology from the perspective of patients, hospitals and payers for the first time at a press conference held by BIOTRONIK at the European Society of Cardiology’s annual congress, ESC Congress 2014. [More]
Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

Extracting Cardiac Leads: An Interview with Barry Norlander from Cook Medical

The pacemaker or ICD unit, which is the implanted box or generator i.e. the electrical component of the device that's implanted in the chest, usually lasts between seven to 10 years before the generator’s battery is depleted. [More]
Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring of implanted pacemakers and defibrillators: an interview with Dr. Suneet Mittal

Remote monitoring is the ability to follow patients who have implantable pacemakers or defibrillators from home. This technology was introduced in the U.S. in 2001 so it’s been available for close to 15 years. [More]
Advertisement
Advertisement